Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling.

Yeo T, Probert F, Jurynczyk M, Sealey M, Cavey A, Claridge TDW, Woodhall M, Waters P, Leite MI, Anthony DC, Palace J.

Neurol Neuroimmunol Neuroinflamm. 2019 Oct 28;6(6):e626. doi: 10.1212/NXI.0000000000000626. Print 2019 Nov.

2.

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD.

Prain K, Woodhall M, Vincent A, Ramanathan S, Barnett MH, Bundell CS, Parratt JDE, Silvestrini RA, Bukhari W; Australian and New Zealand NMO Collaboration, Brilot F, Waters P, Broadley SA.

Front Neurol. 2019 Oct 4;10:1028. doi: 10.3389/fneur.2019.01028. eCollection 2019.

3.

Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.

Waters P, Fadda G, Woodhall M, O'Mahony J, Brown RA, Castro DA, Longoni G, Irani SR, Sun B, Yeh EA, Marrie RA, Arnold DL, Banwell B, Bar-Or A; Canadian Pediatric Demyelinating Disease Network.

JAMA Neurol. 2019 Sep 23. doi: 10.1001/jamaneurol.2019.2940. [Epub ahead of print]

4.

Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.

Petzold A, Woodhall M, Khaleeli Z, Tobin WO, Pittock SJ, Weinshenker BG, Vincent A, Waters P, Plant GT.

J Neurol Neurosurg Psychiatry. 2019 Sep;90(9):1021-1026. doi: 10.1136/jnnp-2019-320493. Epub 2019 May 22.

PMID:
31118222
5.

A multicenter comparison of MOG-IgG cell-based assays.

Waters PJ, Komorowski L, Woodhall M, Lederer S, Majed M, Fryer J, Mills J, Flanagan EP, Irani SR, Kunchok AC, McKeon A, Pittock SJ.

Neurology. 2019 Mar 12;92(11):e1250-e1255. doi: 10.1212/WNL.0000000000007096. Epub 2019 Feb 6.

6.

Characterization of the thymus in Lrp4 myasthenia gravis: Four cases.

Koneczny I, Rennspiess D, Marcuse F, Dankerlui N, Abdul Hamid M, Mané-Damas M, Maessen J, Van Schil P, Saxena A, Zisimopoulou P, Lazaridis K, Woodhall M, Karagiorgou K, Tzartos J, Tzartos S, De Baets MH, Molenaar PC, Marx A, Zur Hausen A, Losen M, Martinez-Martinez P.

Autoimmun Rev. 2019 Jan;18(1):50-55. doi: 10.1016/j.autrev.2018.07.011. Epub 2018 Nov 8.

7.

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.

Lee HJ, Kim B, Waters P, Woodhall M, Irani S, Ahn S, Kim SJ, Kim SM.

J Neuroinflammation. 2018 Oct 31;15(1):302. doi: 10.1186/s12974-018-1335-x.

8.

Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.

Park KH, Waters P, Woodhall M, Lang B, Smith T, Sung JJ, Kim KK, Lim YM, Kim JE, Kim BJ, Park JS, Lim JG, Kim DS, Kwon O, Sohn EH, Bae JS, Yoon BN, Kim NH, Ahn SW, Oh J, Park HJ, Shin KJ, Hong YH.

PLoS One. 2018 Jun 29;13(6):e0200225. doi: 10.1371/journal.pone.0200225. eCollection 2018.

9.

Antiglycine receptor antibody related disease: a case series and literature review.

Swayne A, Tjoa L, Broadley S, Dionisio S, Gillis D, Jacobson L, Woodhall MR, McNabb A, Schweitzer D, Tsang B, Vincent A, Irani SR, Wong R, Waters P, Blum S.

Eur J Neurol. 2018 Oct;25(10):1290-1298. doi: 10.1111/ene.13721. Epub 2018 Jul 21. Review.

10.

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.

Park KH, Waters P, Woodhall M, Lang B, Smith T, Sung JJ, Kim KK, Lim YM, Kim JE, Kim BJ, Park JS, Lim JG, Kim DS, Kwon O, Sohn EH, Bae JS, Yoon BN, Kim NH, Ahn SW, Oh J, Park HJ, Shin KJ, Hong YH.

PLoS One. 2018 Mar 8;13(3):e0193723. doi: 10.1371/journal.pone.0193723. eCollection 2018. Erratum in: PLoS One. 2018 Jun 29;13(6):e0200225.

11.

Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.

Hyun JW, Huh SY, Shin HJ, Woodhall M, Kim SH, Irani SR, Lee SH, Waters P, Kim HJ.

Mult Scler. 2019 Apr;25(4):585-590. doi: 10.1177/1352458518761186. Epub 2018 Mar 7.

12.

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.

Wilson R, Makuch M, Kienzler AK, Varley J, Taylor J, Woodhall M, Palace J, Leite MI, Waters P, Irani SR.

Brain. 2018 Apr 1;141(4):1063-1074. doi: 10.1093/brain/awy010.

13.

Serological and experimental studies in different forms of myasthenia gravis.

Vincent A, Huda S, Cao M, Cetin H, Koneczny I, Rodriguez Cruz PM, Jacobson L, Viegas S, Jacob S, Woodhall M, Nagaishi A, Maniaol A, Damato V, Leite MI, Cossins J, Webster R, Palace J, Beeson D.

Ann N Y Acad Sci. 2018 Feb;1413(1):143-153. doi: 10.1111/nyas.13592. Epub 2018 Jan 29. Review. Erratum in: Ann N Y Acad Sci. 2018 Apr;1417(1):130.

PMID:
29377162
14.

Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.

Jurynczyk M, Probert F, Yeo T, Tackley G, Claridge TDW, Cavey A, Woodhall MR, Arora S, Winkler T, Schiffer E, Vincent A, DeLuca G, Sibson NR, Isabel Leite M, Waters P, Anthony DC, Palace J.

Acta Neuropathol Commun. 2017 Dec 6;5(1):95. doi: 10.1186/s40478-017-0495-8.

15.

A nationwide epidemiological study of myasthenia gravis in Latvia.

Zieda A, Ravina K, Glazere I, Pelcere L, Naudina MS, Liepina L, Kamsa I, Kurjane N, Woodhall M, Jacobson L, Leite MI, Tandon K, Kenina V.

Eur J Neurol. 2018 Mar;25(3):519-526. doi: 10.1111/ene.13535. Epub 2018 Jan 8.

PMID:
29194859
16.

Clinical presentation and prognosis in MOG-antibody disease: a UK study.

Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J.

Brain. 2017 Dec 1;140(12):3128-3138. doi: 10.1093/brain/awx276. Erratum in: Brain. 2018 Apr 1;141(4):e31.

PMID:
29136091
17.

Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease.

Hamid SHM, Whittam D, Saviour M, Alorainy A, Mutch K, Linaker S, Solomon T, Bhojak M, Woodhall M, Waters P, Appleton R, Duddy M, Jacob A.

JAMA Neurol. 2018 Jan 1;75(1):65-71. doi: 10.1001/jamaneurol.2017.3196.

18.

Predictors of outcome in a large retrospective cohort of patients with transverse myelitis.

Gastaldi M, Marchioni E, Banfi P, Mariani V, Di Lodovico L, Bergamaschi R, Alfonsi E, Borrelli P, Ferraro OE, Zardini E, Pichiecchio A, Cortese A, Waters P, Woodhall M, Ceroni M, Mauri M, Franciotta D.

Mult Scler. 2018 Nov;24(13):1743-1752. doi: 10.1177/1352458517731911. Epub 2017 Oct 2.

PMID:
28967297
19.

Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.

Hyun JW, Woodhall MR, Kim SH, Jeong IH, Kong B, Kim G, Kim Y, Park MS, Irani SR, Waters P, Kim HJ.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):811-817. doi: 10.1136/jnnp-2017-315998. Epub 2017 Jul 6.

PMID:
28684532
20.

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG.

Huda S, Waters P, Woodhall M, Leite MI, Jacobson L, De Rosa A, Maestri M, Ricciardi R, Heckmann JM, Maniaol A, Evoli A, Cossins J, Hilton-Jones D, Vincent A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 5;4(4):e357. doi: 10.1212/NXI.0000000000000357. eCollection 2017 Jul.

21.

Incidence and prevalence of NMOSD in Australia and New Zealand.

Bukhari W, Prain KM, Waters P, Woodhall M, O'Gorman CM, Clarke L, Silvestrini RA, Bundell CS, Abernethy D, Bhuta S, Blum S, Boggild M, Boundy K, Brew BJ, Brown M, Brownlee WJ, Butzkueven H, Carroll WM, Chen C, Coulthard A, Dale RC, Das C, Dear K, Fabis-Pedrini MJ, Fulcher D, Gillis D, Hawke S, Heard R, Henderson APD, Heshmat S, Hodgkinson S, Jimenez-Sanchez S, Killpatrick T, King J, Kneebone C, Kornberg AJ, Lechner-Scott J, Lin MW, Lynch C, Macdonell R, Mason DF, McCombe PA, Pender MP, Pereira JA, Pollard JD, Reddel SW, Shaw C, Spies J, Stankovich J, Sutton I, Vucic S, Walsh M, Wong RC, Yiu EM, Barnett MH, Kermode AG, Marriott MP, Parratt JDE, Slee M, Taylor BV, Willoughby E, Wilson RJ, Vincent A, Broadley SA.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):632-638. doi: 10.1136/jnnp-2016-314839. Epub 2017 May 26.

22.

Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity.

Chang T, Waters P, Woodhall M, Vincent A.

Neurologist. 2017 May;22(3):101-102. doi: 10.1097/NRL.0000000000000122.

PMID:
28471902
23.

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.

Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, DeLuca G, Chandratre S, Leite MI, Vincent A, Palace J.

Brain. 2017 Mar 1;140(3):617-627. doi: 10.1093/brain/aww350.

PMID:
28364548
24.

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease.

Juryńczyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M, Waters P, Kuker W, Craner M, Weir A, DeLuca GC, Kremer S, Leite MI, Vincent A, Jacob A, de Sèze J, Palace J.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):132-136. doi: 10.1136/jnnp-2016-314005. Epub 2016 Oct 8.

PMID:
27951522
25.

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis.

Tackley G, Vecchio D, Hamid S, Jurynczyk M, Kong Y, Gore R, Mutch K, Woodhall M, Waters P, Vincent A, Leite MI, Tracey I, Jacob A, Palace J.

J Neurol Neurosurg Psychiatry. 2017 Feb;88(2):165-169. doi: 10.1136/jnnp-2016-314991. Epub 2016 Nov 24.

PMID:
27884934
26.

Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.

Rivas JR, Ireland SJ, Chkheidze R, Rounds WH, Lim J, Johnson J, Ramirez DM, Ligocki AJ, Chen D, Guzman AA, Woodhall M, Wilson PC, Meffre E, White C 3rd, Greenberg BM, Waters P, Cowell LG, Stowe AM, Monson NL.

Acta Neuropathol. 2017 Jan;133(1):43-60. doi: 10.1007/s00401-016-1627-0. Epub 2016 Oct 11.

27.

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G.

Kim SM, Waters P, Woodhall M, Kim YJ, Kim JA, Cheon SY, Lee S, Jo SR, Kim DG, Jung KC, Lee KW, Sung JJ, Park KS.

Mult Scler. 2017 Jul;23(8):1104-1111. doi: 10.1177/1352458516674366. Epub 2016 Oct 19.

PMID:
27760862
28.

Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children.

Chan DWS, Thomas T, Lim M, Ling S, Woodhall M, Vincent A.

Eur J Paediatr Neurol. 2017 Mar;21(2):414-417. doi: 10.1016/j.ejpn.2016.08.013. Epub 2016 Sep 12.

PMID:
27653852
29.

Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.

Tackley G, O'Brien F, Rocha J, Woodhall M, Waters P, Chandratre S, Halfpenny C, Hemingway C, Wassmer E, Wasiewski W, Leite MI, Palace J.

Mult Scler Relat Disord. 2016 May;7:21-5. doi: 10.1016/j.msard.2016.02.014. Epub 2016 Feb 16.

PMID:
27237752
30.

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.

Waters P, Reindl M, Saiz A, Schanda K, Tuller F, Kral V, Nytrova P, Sobek O, Nielsen HH, Barington T, Lillevang ST, Illes Z, Rentzsch K, Berthele A, Berki T, Granieri L, Bertolotto A, Giometto B, Zuliani L, Hamann D, van Pelt ED, Hintzen R, Höftberger R, Costa C, Comabella M, Montalban X, Tintoré M, Siva A, Altintas A, Deniz G, Woodhall M, Palace J, Paul F, Hartung HP, Aktas O, Jarius S, Wildemann B, Vedeler C, Ruiz A, Leite MI, Trillenberg P, Probst M, Saschenbrecker S, Vincent A, Marignier R.

J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):1005-15. doi: 10.1136/jnnp-2015-312601. Epub 2016 Apr 25.

31.

Characteristics Of acetylcholine-receptor-antibody-negative myasthenia gravis in a South African cohort.

Huda S, Woodhall MR, Vincent A, Heckmann JM.

Muscle Nerve. 2016 Dec;54(6):1023-1029. doi: 10.1002/mus.25154. Epub 2016 Oct 13.

PMID:
27105303
32.

Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.

Piccolo L, Woodhall M, Tackley G, Juryńczyk M, Kong Y, Domingos J, Gore R, Vincent A, Waters P, Leite MI, Palace J.

J Neurol. 2016 Feb;263(2):370-379. doi: 10.1007/s00415-015-7983-1. Epub 2015 Dec 14.

PMID:
26668077
33.

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.

Nour MM, Nakashima I, Coutinho E, Woodhall M, Sousa F, Revis J, Takai Y, George J, Kitley J, Santos ME, Nour JM, Cheng F, Kuroda H, Misu T, Martins-da-Silva A, DeLuca GC, Vincent A, Palace J, Waters P, Fujihara K, Leite MI.

Neurology. 2016 Jan 5;86(1):79-87. doi: 10.1212/WNL.0000000000002208. Epub 2015 Nov 18.

34.

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.

Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, Lee KW, Waters P.

Neurol Neuroimmunol Neuroinflamm. 2015 Oct 15;2(6):e163. doi: 10.1212/NXI.0000000000000163. eCollection 2015 Dec.

35.

Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.

Kitley J, Woodhall M, Leite MI, Palace J, Vincent A, Waters P.

Neurol Neuroimmunol Neuroinflamm. 2015 Jun 18;2(4):e121. doi: 10.1212/NXI.0000000000000121. eCollection 2015 Aug.

36.

Paraneoplastic neurologic disorders in small cell lung carcinoma: A prospective study.

Gozzard P, Woodhall M, Chapman C, Nibber A, Waters P, Vincent A, Lang B, Maddison P.

Neurology. 2015 Jul 21;85(3):235-9. doi: 10.1212/WNL.0000000000001721. Epub 2015 Jun 24.

37.

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.

Rodríguez Cruz PM, Al-Hajjar M, Huda S, Jacobson L, Woodhall M, Jayawant S, Buckley C, Hilton-Jones D, Beeson D, Vincent A, Leite MI, Palace J.

JAMA Neurol. 2015 Jun;72(6):642-9. doi: 10.1001/jamaneurol.2015.0203.

38.

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Juryńczyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e89. doi: 10.1212/NXI.0000000000000089. eCollection 2015 Jun.

39.

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies.

Morris KA, Waters P, Woodhall MR, Kuker W, Vincent A, Leite MI, Sen A.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 19;2(3):e88. doi: 10.1212/NXI.0000000000000088. eCollection 2015 Jun. No abstract available.

40.

Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children.

Hacohen Y, Absoud M, Deiva K, Hemingway C, Nytrova P, Woodhall M, Palace J, Wassmer E, Tardieu M, Vincent A, Lim M, Waters P.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 12;2(2):e81. doi: 10.1212/NXI.0000000000000081. eCollection 2015 Apr.

41.

Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy.

Zuliani L, Ferlazzo E, Andrigo C, Casano A, Cianci V, Zoccarato M, Leite MI, Waters P, Woodhall M, Della Mora E, Morra M, Giometto B, Aguglia U, Vincent A.

Neurol Neuroimmunol Neuroinflamm. 2014 Jul 3;1(2):e16. doi: 10.1212/NXI.0000000000000016. eCollection 2014 Aug. No abstract available.

42.

Complement activation in patients with neuromyelitis optica.

Nytrova P, Potlukova E, Kemlink D, Woodhall M, Horakova D, Waters P, Havrdova E, Zivorova D, Vincent A, Trendelenburg M.

J Neuroimmunol. 2014 Sep 15;274(1-2):185-91. doi: 10.1016/j.jneuroim.2014.07.001. Epub 2014 Jul 11.

PMID:
25109258
43.

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.

Absoud M, Lim MJ, Appleton R, Jacob A, Kitley J, Leite MI, Pike MG, Vincent A, Wassmer E, Waters P, Woodhall M, Hemingway C, Palace J.

J Neurol Neurosurg Psychiatry. 2015 Apr;86(4):470-2. doi: 10.1136/jnnp-2014-308550. Epub 2014 Aug 4.

PMID:
25091363
44.

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.

Carvajal-González A, Leite MI, Waters P, Woodhall M, Coutinho E, Balint B, Lang B, Pettingill P, Carr A, Sheerin UM, Press R, Lunn MP, Lim M, Maddison P, Meinck HM, Vandenberghe W, Vincent A.

Brain. 2014 Aug;137(Pt 8):2178-92. doi: 10.1093/brain/awu142. Epub 2014 Jun 20. Erratum in: Brain. 2014 Dec;137(Pt 12):e315. Press, Raomand [corrected to Press, Rayomand].

45.

Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder.

Wuerfel E, Bien CG, Vincent A, Woodhall M, Brockmann K.

J Neurol Sci. 2014 Aug 15;343(1-2):180-2. doi: 10.1016/j.jns.2014.05.014. Epub 2014 May 15.

PMID:
24880541
46.

Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status.

Kim SM, Waters P, Woodhall M, Yang JW, Yang H, Kim JE, Sung JJ, Park KS, Lee KW.

BMC Neurol. 2014 Apr 29;14:93. doi: 10.1186/1471-2377-14-93.

47.

Investigation of neuronal autoantibodies in two different focal epilepsy syndromes.

Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S, Bebek N, Gurses C, Gokyigit A, Waters P, Vincent A, Baykan B.

Epilepsia. 2014 Mar;55(3):414-22. doi: 10.1111/epi.12528. Epub 2014 Feb 6.

48.

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.

Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Küker W, Chandratre S, Vincent A, Palace J.

JAMA Neurol. 2014 Mar;71(3):276-83. doi: 10.1001/jamaneurol.2013.5857.

PMID:
24425068
49.

Functionality of the three-site ferroxidase center of Escherichia coli bacterial ferritin (EcFtnA).

Bou-Abdallah F, Yang H, Awomolo A, Cooper B, Woodhall MR, Andrews SC, Chasteen ND.

Biochemistry. 2014 Jan 28;53(3):483-95. doi: 10.1021/bi401517f. Epub 2014 Jan 14.

50.

Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.

Hacohen Y, Absoud M, Woodhall M, Cummins C, De Goede CG, Hemingway C, Jardine PE, Kneen R, Pike MG, Whitehouse WP, Wassmer E, Waters P, Vincent A, Lim M; UK & Ireland Childhood CNS Inflammatory Demyelination Working Group.

J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):456-61. doi: 10.1136/jnnp-2013-306411. Epub 2013 Oct 16.

PMID:
24133290

Supplemental Content

Loading ...
Support Center